Incyte Corp (INCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | INCY | AMGN | CELG | GILD | BIIB |
| Company | Incyte Corp | Amgen Inc | Celgene Corp | Gilead Sciences Inc | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 65.25 | 333.93 | 108.01 | 83.37 | 198.13 |
| High | 66.08 | 339.00 | 108.59 | 84.52 | 199.68 |
| Low | 64.38 | 331.00 | 107.27 | 82.76 | 196.81 |
| Last | 65.30 | 333.40 | 108.24 | 84.16 | 198.59 |
| Change | -1.13 | +0.60 | +0.11 | +1.11 | +0.38 |
| % Change | -1.70% | +0.18% | +0.10% | +1.34% | +0.19% |
| Volume | 1,454,177 | 729,431 | 191,230,496 | 5,653,285 | 348,392 |
| 20-Day Average Volume | 1,783,572 | 1,702,390 | 16,188,930 | 6,242,152 | 784,901 |
| Previous Close | 66.43 | 332.80 | 108.13 | 83.05 | 198.21 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | No | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 64.41 | 329.45 | 108.17 | 79.66 | 201.93 |
| 20-Day Raw Stochastic | 70.18% | 90.82% | 63.25% | 95.34% | 47.26% |
| 20-Day Relative Strength | 56.38% | 58.23% | 64.69% | 72.80% | 42.12% |
| Weighted Alpha | +16.88 | +27.59 | +46.30 | +19.25 | -22.66 |
| Today's Opinion | 100% Buy | 96% Buy | 100% Buy | 88% Buy | 100% Sell |
| Previous Opinion | 100% Buy | 88% Buy | 100% Buy | 88% Buy | 100% Sell |
| Last Month's Opinion | 72% Buy | 72% Buy | 100% Buy | 40% Buy | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.19% since 09/11/24 | +2.10% since 09/11/24 | -1.97% since 11/13/19 | +4.30% since 09/11/24 | +0.21% since 09/11/24 |
| Low | 61.63 on 09/12/24 | 326.41 on 09/12/24 | 107.27 on 11/20/19 | 81.57 on 09/13/24 | 192.25 on 09/13/24 |
| High | 67.74 on 09/17/24 | 338.72 on 09/18/24 | 110.53 on 11/14/19 | 84.89 on 09/12/24 | 202.79 on 09/17/24 |
| 1-Month | |||||
| %Chg | +5.82% since 08/16/24 | +4.81% since 08/16/24 | +5.14% since 10/18/19 | +14.42% since 08/16/24 | -1.19% since 08/16/24 |
| Low | 61.15 on 09/05/24 | 319.00 on 09/06/24 | 102.40 on 10/21/19 | 73.27 on 08/19/24 | 192.25 on 09/13/24 |
| High | 67.74 on 09/17/24 | 338.72 on 09/18/24 | 110.70 on 11/13/19 | 84.89 on 09/12/24 | 207.59 on 08/21/24 |
| 3-Month | |||||
| %Chg | +7.06% since 06/18/24 | +10.10% since 06/18/24 | +13.63% since 08/20/19 | +33.68% since 06/18/24 | -10.80% since 06/18/24 |
| Low | 56.75 on 07/05/24 | 303.55 on 06/20/24 | 93.41 on 08/23/19 | 64.86 on 06/20/24 | 192.25 on 09/13/24 |
| High | 70.36 on 07/25/24 | 346.85 on 07/25/24 | 110.70 on 11/13/19 | 84.89 on 09/12/24 | 238.00 on 07/12/24 |
| 6-Month | |||||
| %Chg | +14.71% since 03/18/24 | +24.37% since 03/18/24 | +14.14% since 05/20/19 | +15.23% since 03/18/24 | -9.07% since 03/18/24 |
| Low | 50.35 on 04/30/24 | 260.68 on 04/19/24 | 89.08 on 07/23/19 | 62.07 on 05/31/24 | 189.44 on 04/19/24 |
| High | 70.36 on 07/25/24 | 346.85 on 07/25/24 | 110.70 on 11/13/19 | 84.89 on 09/12/24 | 238.00 on 07/12/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 14,916,259 | 178,525,568 | 77,035,920 | 103,468,096 | 28,858,782 |
| Shares Outstanding, K | 224,541 | 536,435 | 711,714 | 1,245,853 | 145,597 |
| Annual Sales | 3,695,650,000 | 28,190,000,000 | 15,281,000,000 | 27,116,000,000 | 9,835,600,000 |
| Annual Net Income | 597,600,000 | 6,717,000,000 | 4,046,000,000 | 5,665,000,000 | 1,161,100,000 |
| Last Quarter Sales | 1,043,760,000 | 8,388,000,000 | 4,520,000,000 | 6,954,000,000 | 2,464,900,000 |
| Last Quarter Net Income | -444,600,000 | 746,000,000 | 1,691,000,000 | 1,614,000,000 | 583,600,000 |
| 60-Month Beta | 0.73 | 0.61 | 1.41 | 0.18 | -0.06 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.82 on 07/30/24 | 4.97 on 08/06/24 | 2.99 on 10/31/19 | 2.01 on 08/08/24 | 5.28 on 08/01/24 |
| Latest Earnings Date | 10/29/24 | 10/29/24 | 10/31/19 | 11/05/24 | 08/01/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | 0.770 on 09/13/24 | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | N/A | 09/13/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 830.12 | 18.02 | 10.99 | 17.69 | 12.27 |